Jushi Q2 FY26 net loss narrows 41% to USD 7.33 million; revenue rises 10% to USD 71.3 million

• Jushi posted a net loss of USD 7.33 million, narrowing from a year earlier; revenue rose 10% to USD 71.3 million.
• Operating income fell 80% to USD 714,000 as operating expenses climbed 22% to USD 30.82 million.
• Interest expense eased 3% to USD 9.89 million; income tax swung to a USD 976,000 benefit on federal rescheduling eliminating 280E for qualifying medical cannabis.
• Adjusted EBITDA (non-GAAP) slipped 3% to USD 13.34 million.
• Virginia’s adult-use market framework sets retail sales to start July 1, 2027; shareholders backed a plan to domesticate the company in Nevada.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jushi Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-050207), on July 28, 2026, and is solely responsible for the information contained therein.